4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-060311
Chief Executive Officer sold 7,800 shares at an average $40.39 ($315,035)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2018-11-28 | Sale | −2,700 | $38.65 | $104,355 | 32,578 | I: show line 1 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2018-11-28 | Sale | −1,200 | $39.54 | $47,448 | 31,378 | I: show line 2 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2018-11-29 | Sale | −1,400 | $41.13 | $57,582 | 29,978 | I: show line 3 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2018-11-29 | Sale | −2,500 | $42.26 | $105,650 | 27,478 | I: show line 4 in the form |
| Open-market sales · 7,800 sh · avg $40.39 · $315,035 | |||||||
Loading xslF345X03/doc4.xml…